e-mail
info@biokimyo.uz
Sales department
+998 (77) 184-84-71
Uz
Рус
En
Ру
Ўз
O'z
About company
HISTORY company
Information about main indicators
Subject and objectives of activity
Dynamics of development
Company development strategy
Business plan
Material of the mass media about join-stock company
SWOT - Analysis
MATERIAL OF THE MASS MEDIA ABOUT JOIN-STOCK COMPANY
Vacancies
Youth Politics
Information about specialitits
Youth progpams
Normativ documents
Corporate governance
Manual
Compliance Service
Reports
Emitent annual reports
Emitent Quarterly report
Shareholders
Company passport
Charter of the company
Internal documents of the company
Affilates
Dividends
Prospectus of issue
General information on the distribution of shares
Rights of Shareholders
Principles of corporate managment
Audit reports
organizational structure
Information on the organizations of the company
Supervisory board
Executive body
Engineering Technical Council
Counting Commission
Composition of the committee of minority shareholders
Information about control bodies
Audit committee
Internal audit service
Corporate consultant
Essential facts
Convening a general meeting
36-Essential facts
Voting results
Accrued and paid remuneration
Production
Ethyl alcohol recticed from grain
Etil spirti rektifikatsiyalangan texnik
Technological steam
Product prices
Product prices
Sales of alcohol
state procurements
Contests and tenders
Purchase plan
Procurement Commission
Information on purchases made
xt-xarid.uz
cooperation.uz
eshop.uzex.uz
emilliydokon.uzex.uz
exarid.uzex.uz
direct contracts awarded
Import
license
license
Sertificates
News and announciments
Contacts
Appeals
Schedule reception
Procedure to consider the appeals of individuals and legal entities
Report competition restriction
Forum
Quetion - answer
Survey
About company
HISTORY company
Information about main indicators
Subject and objectives of activity
Dynamics of development
Company development strategy
Business plan
Material of the mass media about join-stock company
SWOT - Analysis
MATERIAL OF THE MASS MEDIA ABOUT JOIN-STOCK COMPANY
Vacancies
Youth Politics
Information about specialitits
Youth progpams
Normativ documents
Corporate governance
Manual
Compliance Service
Reports
Emitent annual reports
Emitent Quarterly report
Shareholders
Company passport
Charter of the company
Internal documents of the company
Affilates
Dividends
Prospectus of issue
General information on the distribution of shares
Rights of Shareholders
Principles of corporate managment
Audit reports
organizational structure
Information on the organizations of the company
Supervisory board
Executive body
Engineering Technical Council
Counting Commission
Composition of the committee of minority shareholders
Information about control bodies
Audit committee
Internal audit service
Corporate consultant
Essential facts
Convening a general meeting
36-Essential facts
Voting results
Accrued and paid remuneration
Production
Ethyl alcohol recticed from grain
Etil spirti rektifikatsiyalangan texnik
Technological steam
Product prices
Product prices
Sales of alcohol
state procurements
Contests and tenders
Purchase plan
Procurement Commission
Information on purchases made
xt-xarid.uz
cooperation.uz
eshop.uzex.uz
emilliydokon.uzex.uz
exarid.uzex.uz
direct contracts awarded
Import
license
license
Sertificates
News and announciments
Contacts
Appeals
Schedule reception
Procedure to consider the appeals of individuals and legal entities
Report competition restriction
Forum
Quetion - answer
News and announcements
Home
News and announcements
16 January 2017
GRACE LETTER
Latest news
Based on the results of the assessment of the company's corporate governance system for the of 12 month 2024 year: “LEADER FINANCE CAPITAL” i submitted a report on the assessment of the corporate department of the Company No. 21/02 dated fevral 13, 2025. According to the results of the evaluation of the corporate management system, the final number of points amounted to 1033 points, that is, 86,0 %, and according to “LEADER FINANCE CAPITAL”, the corporate control system in Biokimyo JSC according to the results of the 12 month of 2024 is recognized High" As a result of the study of the assessment of the corporate governance system, revealed: Notes on not following Codex recommendations Explanation II. Assessment of compliance with the recommendations of the Corporate Governance Code. clause 14. The composition of the Supervisory Board of JSC are not independent of the Supervisory Board The new composition of the Supervisory Board was elected at the extraordinary general meeting of shareholders on june 29, 2024, where independent candidates participated, but they did not receive the largest votes during the voting VII. Evaluation of information policy p.1.12, p.1.13, p.2.12, p.3.12. Completeness of disclosure of information on the JSC's website: p.1.12. Name of structural divisions, branches, representative offices, subsidiaries and dependent business entities, their phone numbers, addresses (postal and electronic), information about the order of their work; Item 1.31. video about the investment attractiveness of JSC Clause 1.12. The Company does not have structural divisions, branches, representative offices, subsidiaries and dependent business entities, in this regard, there is no information and information about them on the website; item 1.31. The main territory of the society is a categorized object, in this regard, videos are not published on the website, but videos of the media are published. VIII. Assessment of financial results p. 1-p.4. According to the results of the 12 month 2024 year, accounts receivable increased compared to the beginning of the reporting year. There is no overdue debt. The main reason for the increase in accounts receivable:advance payments for raw materials. Accounts payable increased compared to the beginning of the reporting year. There is no overdue debt. The main reason for the increase in creditworthiness is the accrued dividends of shareholders according to the decision of the annual General Meeting of Shareholders dated 06/18/2024.
JSC "BIOKIMYO" announces that it will receive a commercial offer and a medical obsledovaniya sotrudnikov in November 2024.
Voice reading
×
The site has a voice reading feature, select the text you want to hear, and press the button
Click on the button below to listen to the text
Powered by
GSpeech